Featured Research

from universities, journals, and other organizations

Mitral-Valve Prolapse Less Common, Less Harmful Than Previously Thought

Date:
July 2, 1999
Source:
National Heart, Lung, And Blood Institute
Summary:
Researchers from the National Heart, Lung, and Blood Institute's (NHLBI) Framingham Heart Study report that mitral-valve prolapse (MVP), a condition in which a valve in the heart is abnormally long and floppy, is substantially less common and less serious than previously believed.

Researchers from the National Heart, Lung, and Blood Institute's (NHLBI) Framingham Heart Study report that mitral-valve prolapse (MVP), a condition in which a valve in the heart is abnormally long and floppy, is substantially less common and less serious than previously believed. In a study appearing in the July 1, 1999 issue of The New England Journal of Medicine, the researchers report that MVP affects about 2 percent of the population rather than the 5 to 35 percent of the population indicated in earlier estimates. And, contradicting earlier studies suggesting that MVP occurs more commonly in women, the researchers found that men and women are equally likely to have the condition. "This is very compelling information," said Dr. Claude Lenfant, Director of the NHLBI, "It may mean people who have been diagnosed with mitral valve prolapse should consult their physician to discuss their health status. It also indicates that further, longer-term studies are called for to resolve this issue definitively and to define the natural history of this condition," he said.

Diagnoses of mitral-valve prolapse increased significantly in the late 1970s and early 1980s with the advent of ultrasound technology which, for the first time, enabled doctors to view the mitral valve noninvasively. According to Dr. Emelia Benjamin, the senior investigator, the earlier studies were conducted using M-mode technology, a form of echocardiography, and often resulted in over diagnosis of MVP. This study was undertaken in part because of the availability of newer, more accurate echocardiographic criteria for mitral-valve prolapse developed by co-author Robert A. Levine, MD. The criteria allowed the researchers to address the validity of the diagnosis of mitral-valve prolapse occurring in an alarming proportion of the population.

Using standard echocardiographic equipment along with the new criteria, which minimizes false positive and false negative diagnoses, the researchers evaluated mitral-valve prolapse status in 3,491 participants in the Framingham Heart Study. Of these, 84 (2.4 percent) had MVP.

"With this study, we may have tempered the notion that mitral-valve prolapse is the most common cardiac valvular abnormality in industrialized countries," said Dr. Lisa Freed, the study's lead author. "In addition, the low frequency of associated complications may allay anxiety for those in whom mitral-valve prolapse is diagnosed in an outpatient setting," she said.

Dr. Benjamin noted the value of conducting this study in a community setting because community studies give a more representative picture of MVP and its clinical features. "Prior studies using echocardiography have involved patients in university hospitals who tend to have more severe abnormalities or symptoms," she said.

In addition to being thought to have a high prevalence rate, MVP has often been portrayed as a disease with frequent and serious complications, including stroke, atrial fibrillation, heart failure. The researchers found that these complications did not occur at higher rates among patients with mitral-valve prolapse compared to those patients without prolapse.

The authors point out that the participants in this study were predominantly white and the results may not apply to other ethnic and racial groups.

Another NHLBI-funded study on MVP appearing in the same issue of The New England Journal of Medicine found that the condition was no more common among young people (45 years old or younger) with stroke or transient ischemic stroke (TIA or mini stroke) than it was among a control group of patients. The issue of a possible connection between MVP and stroke -- especially in young patients -- has been a long-standing controversy. The new study by Dan Gilon, M.D., Robert Levine, M.D. (a co-author of the Framingham study), and colleagues at Massachusetts General Hospital and Harvard Medical School also involved the use of the same new, more accurate echocardiographic criteria. The scientists report that they could not show an association between MVP and acute "ischemic neurologic events" (stroke) in young people.


Story Source:

The above story is based on materials provided by National Heart, Lung, And Blood Institute. Note: Materials may be edited for content and length.


Cite This Page:

National Heart, Lung, And Blood Institute. "Mitral-Valve Prolapse Less Common, Less Harmful Than Previously Thought." ScienceDaily. ScienceDaily, 2 July 1999. <www.sciencedaily.com/releases/1999/07/990702080118.htm>.
National Heart, Lung, And Blood Institute. (1999, July 2). Mitral-Valve Prolapse Less Common, Less Harmful Than Previously Thought. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1999/07/990702080118.htm
National Heart, Lung, And Blood Institute. "Mitral-Valve Prolapse Less Common, Less Harmful Than Previously Thought." ScienceDaily. www.sciencedaily.com/releases/1999/07/990702080118.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins